UnitedHealth Group (NYSE:UNH) Stock Sold by Rep. Maria Elvira Salazar

Representative Maria Elvira Salazar (Republican-Florida) recently sold shares of UnitedHealth Group Incorporated (NYSE:UNH). In a filing disclosed on October 7th, the Representative disclosed that they had sold between $1,001 and $15,000 in UnitedHealth Group stock on September 24th. The trade occurred in the Representative’s “UBS IRA ACCOUNT” account.

Representative Maria Elvira Salazar also recently made the following trade(s):

• Sold $1,001 – $15,000 in shares of Citigroup (NYSE:C) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Chubb (NYSE:CB) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of GE Aerospace (NYSE:GE) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Honeywell International (NASDAQ:HON) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Snowflake (NYSE:SNOW) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of FedEx (NYSE:FDX) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Salesforce (NYSE:CRM) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of RH (NYSE:RH) on 9/24/2026.
• Sold $1,001 – $15,000 in shares of Meta Platforms (NASDAQ:META) on 9/24/2026.

UnitedHealth Group Stock Performance

NYSE UNH opened at $370.54 on Friday. UnitedHealth Group Incorporated has a 1 year low of $255.96 and a 1 year high of $461.62. The firm has a market capitalization of $332.59 billion, a P/E ratio of 23.84, a price-to-earnings-growth ratio of 1.41 and a beta of 0.60. The firm’s fifty day moving average price is $389.50 and its two-hundred day moving average price is $380.30. The company has a current ratio of 0.78, a quick ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 earnings per share for the quarter, beating the consensus estimate of $4.94 by $1.44. The firm had revenue of $112.03 billion for the quarter, compared to analysts’ expectations of $110.81 billion. UnitedHealth Group had a net margin of 3.14% and a return on equity of 16.53%. The business’s revenue was up .4% on a year-over-year basis. During the same period in the prior year, the firm earned $4.08 EPS. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. As a group, research analysts anticipate that UnitedHealth Group Incorporated will post 19.85 EPS for the current year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, September 22nd. Investors of record on Monday, September 14th were issued a dividend of $2.32 per share. This represents a $9.28 dividend on an annualized basis and a yield of 2.5%. The ex-dividend date was Monday, September 14th. UnitedHealth Group’s payout ratio is presently 59.72%.

Wall Street Analysts Forecast Growth

UNH has been the topic of a number of recent analyst reports. Barclays lifted their price objective on shares of UnitedHealth Group from $429.00 to $441.00 and gave the company an “overweight” rating in a research note on Monday, July 20th. Raymond James Financial lifted their price target on shares of UnitedHealth Group from $370.00 to $460.00 and gave the stock an “outperform” rating in a report on Tuesday, July 14th. The Goldman Sachs Group lifted their target price on UnitedHealth Group from $435.00 to $490.00 and gave the stock a “buy” rating in a report on Friday, July 17th. JPMorgan Chase & Co. upped their target price on UnitedHealth Group from $466.00 to $516.00 and gave the company an “overweight” rating in a report on Tuesday, July 21st. Finally, Oppenheimer upped their price objective on shares of UnitedHealth Group from $420.00 to $500.00 and gave the company an “outperform” rating in a research note on Friday, July 17th. Twenty analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $465.75.

Hedge Funds Weigh In On UnitedHealth Group

Several hedge funds have recently made changes to their positions in UNH. BlackRock Inc. increased its holdings in shares of UnitedHealth Group by 4.6% in the second quarter. BlackRock Inc. now owns 76,863,061 shares of the healthcare conglomerate’s stock worth $31,946,594,000 after purchasing an additional 3,395,530 shares during the period. State Street Corp lifted its position in UnitedHealth Group by 0.7% during the second quarter. State Street Corp now owns 45,633,267 shares of the healthcare conglomerate’s stock valued at $18,966,555,000 after purchasing an additional 301,081 shares during the last quarter. Bank of New York Mellon Corp raised its position in UnitedHealth Group by 6.1% during the second quarter. Bank of New York Mellon Corp now owns 10,704,994 shares of the healthcare conglomerate’s stock valued at $4,449,317,000 after purchasing an additional 616,723 shares in the last quarter. Wellington Management Group LLP grew its stake in shares of UnitedHealth Group by 5.8% during the second quarter. Wellington Management Group LLP now owns 10,675,175 shares of the healthcare conglomerate’s stock valued at $4,436,923,000 after buying an additional 583,536 shares during the last quarter. Finally, Corient Private Wealth LP grew its stake in shares of UnitedHealth Group by 1,443.7% in the second quarter. Corient Private Wealth LP now owns 8,447,224 shares of the healthcare conglomerate’s stock worth $3,510,920,000 after purchasing an additional 7,900,011 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

Insiders Place Their Bets

In related news, CEO Patrick Conway sold 1,169 shares of the firm’s stock in a transaction that occurred on Friday, August 21st. The stock was sold at an average price of $390.00, for a total transaction of $455,910.00. Following the completion of the transaction, the chief executive officer owned 15,328 shares of the company’s stock, valued at $5,977,920. This trade represents a 7.09% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Company insiders own 0.19% of the company’s stock.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: UnitedHealth is expected to report third-quarter earnings of roughly $4.12–$4.15 per share on revenue of approximately $111.38 billion. Forecast earnings growth of about 41% reflects expectations for benefits from cost management and restructuring, although revenue growth may remain subdued. UnitedHealth Gears Up for Q3 Earnings
• Positive Sentiment: Analysts and investors are increasingly viewing UnitedHealth’s reduced price-to-earnings valuation as potentially attractive after a difficult period marked by elevated medical costs and pressure across parts of the business. A successful earnings recovery could support a re-rating. UnitedHealth’s P/E Has Reset
• Neutral Sentiment: A Medicare rate decision could provide greater visibility into reimbursement trends and help stabilize expectations for UnitedHealth’s Medicare Advantage operations, but the longer-term effect will depend on medical-cost performance and membership trends. Does a Medicare Rate Decision Steady UnitedHealth Group?
• Neutral Sentiment: Market attention is concentrated on Q3 metrics beyond earnings and revenue, including medical loss ratios, Medicare membership, operating costs and management’s full-year guidance. These factors are likely to determine whether the anticipated earnings rebound is sustainable. UnitedHealth Q3 Earnings Key Metrics
• Negative Sentiment: The stock has underperformed the broader market and is testing an important support level before earnings, signaling investor caution and leaving the shares vulnerable to further weakness if results or guidance disappoint. UnitedHealth Stock Testing Key Support
• Negative Sentiment: A law firm is soliciting UnitedHealth shareholders regarding potential fiduciary-duty issues involving company insiders. The announcement does not establish wrongdoing, but it adds headline and litigation risk ahead of earnings. Shareholder Fiduciary-Duty Inquiry

About Representative Salazar

Maria Elvira Salazar (Republican Party) is a member of the U.S. House, representing Florida’s 27th Congressional District. She assumed office on January 3, 2021. Her current term ends on January 3, 2027.

Salazar (Republican Party) ran for re-election to the U.S. House to represent Florida’s 27th Congressional District. She won in the general election on November 5, 2024.

Maria Elvira Salazar was born in Miami, Florida, and lives in Coral Gables, Florida. Salazar earned an undergraduate degree from the University of Miami in 1983 and a graduate degree from Harvard University in 1995. Her career experience includes working as a television journalist, reporter, and news anchor.

About UnitedHealth Group

UnitedHealth Group Incorporated (NYSE: UNH) is a diversified health care and well-being company serving individuals, employers, health care providers and government programs. Its operations are organized primarily through UnitedHealthcare and Optum.

UnitedHealthcare provides health benefit plans and services, including employer-sponsored coverage, individual and family plans, Medicare and Medicaid offerings, and other government-supported programs. Its services include health insurance administration, pharmacy benefits and care management.

Optum provides health care services, technology and data solutions, pharmacy services, and analytics to health plans, employers, government agencies, health care providers and consumers.